In this webinar join Ed Champness as he describes how a safe and efficacious drug must possess a balance of potency with appropriate ADME and toxicity properties.

The ideal property profile will be different for every project, depending on the therapeutic indication, intended route of administration and commercial factors; the goal of a drug discovery project is to target compounds that are likely to achieve this delicate balance as quickly as possible.

We will discuss how you can achieve this in practice using Optibrium’s StarDrop platform, illustrated with case studies and interactive examples.

Meet the speaker

Ed Champness

CSO, Optibrium


Edmund Champness

More resources